Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-25T05:28:49.842Z Has data issue: false hasContentIssue false
  • English
  • Français

Cost-Effectiveness of the Screening and Treatment of Diabetic Retinopathy: What Are the Costs of Underutilization?

Published online by Cambridge University Press:  10 March 2009

A. Mark Fendrick ,
Jonathan C. Javitt  and
Yen Pin Chiang
A. Mark Fendrick
Affiliation:
Swedish Council on Technology Assessment in Health Care (SBU) and University of Pennsylvania
Jonathan C. Javitt
Affiliation:
Georgetown University Medical Center
Yen Pin Chiang
Affiliation:
Georgetown University Medical Center
Get access Rights & Permissions [Opens in a new window]

Abstract

Diabetic retinal disease remains a leading cause of visual disability among those of working age. Controlled trials have demonstrated that timely diagnosis and photocoagulation treatment can reduce significantly the likelihood of visual impairment in affected diabetic patients. Using a prospective simulation model, we show that an annual screening and treatment program saves thousands of years of vision and reduces medical expenditures over the lifetime of a cohort of Swedish Type I diabetic patients.

Type
General Essays
Information
International Journal of Technology Assessment in Health Care , Volume 8 , Issue 4 , Fall 1992 , pp. 694 - 707
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Agardh, E., Torffvit, O., & Agardh, C. D.The prevalence of retinopathy and associated medical risk in type I diabetes mellitus. Journal of Internal Medicine, 1989, 226, 47–52.CrossRefGoogle Scholar
2.Aylward, G. W., Pearson, R. V., Jagger, J. D., & Hamilton, A. M.Extensive argon laser photocoagulation in the treatment of proliferative diabetic retinopathy. British Journal of Ophthalmology, 1989, 73, 197–201.CrossRefGoogle ScholarPubMed
3.Ballard, D. J., & Melton, L. J. IIISources of disparity in incidence and prevalence of diabetic retinopathy: Influence of selective survival on risk factor assessment. Diabetes Care, 1986, 9, 313–15.CrossRefGoogle ScholarPubMed
4.Ballard, D. J., Melton, L. J., Dwyer, M. S., et al. Risk factors for diabetic retinopathy: A population-based study in Rochester, Minnesota. Diabetes Care, 1986, 9, 334–42.CrossRefGoogle ScholarPubMed
5.British Multicentre Study Group. Photocoagulation for diabetic maculopathy: A randomised controlled clinical trial using the xenon-arc. Diabetes, 1984, 32, 1010–16.Google Scholar
6.British Multicentre Study Group. Photocoagulation for proliferative diabetic retinopathy: A randomised clinical trial using the xenon-arc. Diabetologia, 1984, 26, 109–15.Google Scholar
7.Brorsson, B., & Fendrick, A. M.Swedish Council of Medical Technology Assessment. Survey of 69 Swedish eye clinics with reference to care of diabetes patients. Unpublished data, 1991.Google Scholar
8.Burns-Cox, C. J., & Dean Hart, J. C.Screening of diabetics for retinopathy by ophthalmic opticians. British Medical Journal, 1985, 290, 1052–54.CrossRefGoogle ScholarPubMed
9.Cerutti, F., Sacchetti, C., Vigo, A., et al. Course of retinopathy in children and adolescents with insulin-dependent diabetes mellitus: A ten-year study. Ophthalmologica, 1989, 198, 116–23.CrossRefGoogle ScholarPubMed
10.Cuckle, H. S., & Wald, N. J. Introduction: Principles of screening. In Wald, N. L. (ed.), Antenatal and neonatal screening. Oxford: Oxford University Press, 1984. 1–22.Google Scholar
11.Dahbach, E. J., Fryback, D. G., Newcomb, P. A., et al. Cost-effectiveness of strategies for detecting diabetic retinopathy. Medical Care, 1991, 29, 20–39.CrossRefGoogle Scholar
12.Davis, M. D., Hiller, R., Magli, Y. L., et al. Prognosis for life in patients with diabetes: Relation to severity of retinopathy. Trans-American Ophthalmological Society, 1979, 77, 144–70.Google ScholarPubMed
13.Diabetic Retinopathy Study Research Group. Macular edema in Diabetic Retinopathy Study patients. DRS Report #12. Ophthalmology, 1987, 94, 754–60.CrossRefGoogle Scholar
14.Diabetic Retinopathy Study Research Group. Photocoagulation of proliferative diabetic retinopathy. DRS Report #8. Ophthalmology, 1981, 88, 583–600.CrossRefGoogle Scholar
15.Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: The second report. Ophthalmology, 1978, 85, 82–106.CrossRefGoogle Scholar
16.Diabetic Retinopathy Study Research Group. Preliminary report of effects of photocoagulation therapy. American Journal of Ophthalmology, 1976, 81, 383–96.CrossRefGoogle Scholar
17.Dorman, J. S., LaPorte, R. E., Kuller, A. B., et al. The Pittsburgh insulin-dependent dia betes mellitus morbidity and mortality study: Mortality results. Diabetes, 1984,33,271-76.CrossRefGoogle Scholar
18.Early Treatment Diabetic Retinopathy Study. Color photography vs. fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial. Archives of Ophthalmology, 1987, 105, 1344–51.CrossRefGoogle Scholar
19.Early Treatment Diabetic Retinopathy Study. Detection of diabetic macular edema. Report #5. Ophthalmology, 1989, 96, 746–51.CrossRefGoogle Scholar
20.Early Treatment Diabetic Retinopathy Study. Factors influencing the development of visual loss in advanced diabetic retinopathy. Report #10. Investigative Ophthalmology and Visual Science, 1985, 26, 983–91.Google Scholar
21.Early Treatment Diabetic Retinopathy Study. Photocoagulation for diabetic macular edema. Report #1. Archives of Ophthalmology, 1985, 103, 1796–806.Google Scholar
22.Foulds, W. S., McCuish, A., Barrie, T., et al. Diabetic retinopathy in the west of Scotland: Its detection and prevalence, and the cost-effectiveness of a proposed screening programme. Health Bulletin (Edinburgh), 1983, 41, 318–26.Google ScholarPubMed
23.Goodkin, G.Mortality factors in diabetes: A 20-year mortality study. Journal of Occupational Medicine, 1975, 17, 716–21.Google ScholarPubMed
24.Grey, R. H. B., Burns-Cox, C. J., & Hughes, A.Blind and partial sight registration in Avon. British Journal of Ophthalmology, 1989, 73, 88–94.CrossRefGoogle ScholarPubMed
25.Guidelines for eye care in patients with diabetes mellitus. Archives of Internal Medicine, 1989, 149, 769–70.CrossRefGoogle Scholar
26.Javitt, J. C., Canner, J. K., Frank, R. G., et al. Detecting and treating retinopathy in patients with Type I diabetes mellitus. Ophthalmology, 1990, 97, 483–95.CrossRefGoogle ScholarPubMed
27.Javitt, J. C., Canner, J. K., & Somer, A.Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology, 1989, 96, 255–64.CrossRefGoogle Scholar
28.Jerneld, B.Prevalence of diabetic retinopathy: A population study from the Swedish island of Gotland. Unpublished doctoral dissertation, Department of Ophthalmology, Karolinska Institute, Stockholm, Sweden, 1987.Google Scholar
29.Jerneld, B., & Algvere, P.Prevalence of retinopathy in diabetes treated with oral antihyper glycaemic agents. Acta Ophthalmologica, 1985, 63, 535–40.CrossRefGoogle Scholar
30.Jones, R. B., Larizgoitia, I., Casado, L., & Barrie, T.How effective is the referral chain for diabetic retinopathy? Diabetic Medicine, 1989, 6, 262–66.CrossRefGoogle ScholarPubMed
31.Jönsson, B., & Persson, U.Diabetes: A study in health economics. The Swedish Institute for Health Economics, 1981, 53–57.Google Scholar
32.Kalm, H., Egertsen, R., & Blohmé, G.Non-stereo fundus photography as a screening procedure for diabetic retinopathy among patients with type II diabetes. Acta Ophthalmologica, 1989, 67, 533–46.CrossRefGoogle ScholarPubMed
33.Klein, B. E. K., Davis, M. D., Segal, P., et al. Diabetic retinopathy: Assessment of severity and progression. Ophthalmology, 1984, 91, 10–17.CrossRefGoogle ScholarPubMed
34.Klein, R., Klein, B. E. K., Moss, S. E., et al. A population based study of diabetic retinopathy in insulin-using patients diagnosed before 30 years of age. Diabetes Care, 1985, 8(suppl. 1), 71–76.CrossRefGoogle ScholarPubMed
35.Klein, R., Klein, B. E. K., Moss, S. E., et al. Retinopathy in young-onset diabetic patients. Diabetes Care, 1985, 8, 311–15.CrossRefGoogle ScholarPubMed
36.Klein, R., Klein, B. E. K., Moss, S. E., et al. The Wisconsin Epidemiological Study of Diabetic Retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology, 1984, 102, 520–26.CrossRefGoogle Scholar
37.Klein, R., Klein, B. E. K., Moss, S. E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy VI. Retinal photocoagulation. Ophthalmology, 1987, 94, 747–53.CrossRefGoogle ScholarPubMed
38.Klein, R., Klein, B. E. K., Moss, S. E., et al. The Wisconsin Epidemiological Study of Diabetic Retinopathy IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology, 1989, 107, 237–43.CrossRefGoogle ScholarPubMed
39.Klein, R., Moss, S. E., Klein, B. E. K., et al. Relation of ocular and systemic factors to survival in diabetes. Archives of Internal Medicine, 1989, 149, 266–72.CrossRefGoogle ScholarPubMed
40.Klein, R., Moss, S. E., Klein, B. E. K., et al. The Wisconsin Epidemiological Study of Diabetic Retinopathy XI. The incidence of macular edema. Ophthalmology, 1989,96,1501–10.CrossRefGoogle ScholarPubMed
41.Knatterud, G. L.Mortality experience in the diabetic retinopathy study. Israeli Journal of Medical Science, 1983, 19, 424–28.Google ScholarPubMed
42.Kohner, E. M.The evolution and natural history of diabetic retinopathy. International Ophthalmological Clinics, 1978, 18, 1–16.Google ScholarPubMed
43.Kohner, E. M., & Barry, P. J.Prevention of blindness in diabetic retinopathy. Diabetologia, 1984, 26, 173–79.CrossRefGoogle ScholarPubMed
44.Krolewski, A. S., Warram, J. H., Rand, L. I., et al. Risk for proliferative retinopathy in juvenile onset type one diabetes: A 40-year follow-up study. Diabetes Care, 1986, 9, 443–52.CrossRefGoogle Scholar
45.Lund-Andersen, C., Frost-Larsen, K., & Starup, K.Natural history of diabetic retinopathy in insulin-dependent juvenile diabetics. A longitudinal study. Acta Ophthalmologica, 1987, 65, 481–86.CrossRefGoogle ScholarPubMed
46.McLeod, B. K., Thompson, J. R., & Rosenthal, A. R.The prevalence of retinopathy in the insulin-requiring patients of an English country town. Eye, 1988, 2, 424–30.CrossRefGoogle ScholarPubMed
47.Moss, S. E., Klein, R., Kessler, S. D., et al. Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology, 1985, 92, 62–67.CrossRefGoogle ScholarPubMed
48.Moss, S. E., Klein, R., & Klein, B. E. K.The incidence of visual loss in a diabetic population. Ophthalmology, 1988, 95, 1340–48.CrossRefGoogle Scholar
49.Moss, S. E., Meuer, S. M., Klein, R., et al. Are seven standard photographic fields necessary for classification of diabetic retinopathy? Investigative Ophthalmology and Visual Science, 1989, 30, 823–28.Google ScholarPubMed
50.National Diabetes Data Group. Diabetes in America: Diabetes data compiled 1984. Bethesda, MD: U.S. Department of Health and Human Services. Public Health Services, NIH publication number 85–1468, 1985.Google Scholar
51.Nielsen, N. V.Diabetic retinopathy: The course of retinopathy in insulin-treated diabetics. Acta Ophthalmologica, 1984, 62, 256–65.CrossRefGoogle ScholarPubMed
52.Nyström, L., Dahlquist, G.Östman, J., et al. Risk of developing diabetes mellitus before 35 years of age—Indications of climatological determinants for age at onset. Forthcoming.Google Scholar
53.Okun, E., Johnston, G. P., Boniuk, I., et al. Xenon arc photocoagulation of proliferative diabetic retinopathy. A review of 2688 consecutive eyes in the format of the diabetic retinopathy study. Ophthalmology, 1984, 91, 1458–63.CrossRefGoogle ScholarPubMed
54.Olsen, C. L., Kassoff, A., & Gerber, T.The care of diabetic patients by ophthalmologists in New York state. Ophthalmology, 1989, 96, 739–45.CrossRefGoogle ScholarPubMed
55.Orchard, T. J., Dorman, J. S., Maser, R. E., et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh epidemiology of diabetes complication study II. Diabetes, 1990, 39, 1116–24.CrossRefGoogle ScholarPubMed
56.Palmberg, P., Smith, M., Waltman, S., et al. The natural history of retinopathy in insulindependent juvenile-onset diabetes. Ophthalmology, 1981, 88, 613–18.CrossRefGoogle ScholarPubMed
57.Podgor, M. J., & Leske, M. C.Estimating incidence from age-specific prevalence for irreversible diseases with differential mortality. Statistical Medicine, 1986, 5, 573–78.CrossRefGoogle ScholarPubMed
58.Rohan, T. E., Frost, C. D., & Wald, N. J.Prevention of blindness by screening for diabetic retinopathy: A quantitative assessment. British Medical Journal, 1989, 299, 1198–201.CrossRefGoogle ScholarPubMed
59.Sjølie, A. K., & Green, A.Blindness in insulin-treated diabetic patients with age onset <30 years. Journal of Chronic Disease, 1987, 40, 215–20.CrossRefGoogle ScholarPubMed
60.Stenkula, S. Photocoagulation in diabetic retinopathy. A multicenter study in Sweden. Acta Ophthalmologica, 1984(suppl. 162), 1–100.Google Scholar
61.Weinstein, M. C., Coxson, P. G., Williams, L. W., et al. Forecasting coronary artery disease incidence, mortality and cost: The Coronary Heart Disease Policy Model. American Journal of Public Health, 1987, 77, 1417–26.CrossRefGoogle Scholar
62.WHO Study Group. Diabetes mellitus. Geneva: Technical Report Series, World Health Organization, 1985, 67.Google Scholar
63.Wilson, J. M. G., & Jungner, G.Principles and practice of screening for disease. Geneva: World Health Organization, 1968.Google ScholarPubMed
64.The Wisconsin Epidemiological Study of Diabetic Retinopathy VI. Retinal Photocoagulation. Ophthalmology, 1987, 94, 747–53.CrossRefGoogle Scholar